Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Gibbs

Showing results (21-30 of 427) with videos related to

Pageof 43
Sort By:
Clinical Colorectal Cancer|July 27, 2015
Multidisciplinary Management of Locally Advanced Rectal Cancer--An Evolving Landscape?Margaret Lee, Peter Gibbs, Rachel Wong
JAMA Oncology|June 17, 2021
Is Universal Next-Generation Sequencing Testing of Patients With Advanced Cancer Ready for Prime Time?Catherine Dunn, Lucy Gately, Peter Gibbs
JAMA Oncology|April 3, 2020
Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer-ReplyJeanne Tie, Bert Vogelstein, Peter Gibbs
JAMA Surgery|February 23, 2022
Comment on Timing of Surgery For Patients With Rectal Cancers Not Responding to Preoperative ChemoradiationCatherine Dunn, Lucy Gately, Peter Gibbs
BMC Medicine|September 6, 2023
Re: Molecular testing to deliver personalised chemotherapy recommendationsPeter Gibbs, Wei Hong, Jeanne Tie
Hepatic Oncology|September 8, 2018
Radioembolization for hepatocellular carcinoma: current role and future directions - the medical oncologist's perspectivePeter Gibbs, Jeanne Tie, Lourens Bester
The New England Journal of Medicine|August 19, 2011
Bending the cost curve in cancer careKathryn Field, Ian Faragher, Peter Gibbs
Expert Review of Molecular Diagnostics|September 29, 2017
Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?Jeanne Tie, Christine Semira, Peter Gibbs
The Lancet Regional Health. Western Pacific|June 18, 2025
The emerging clinical utility of ctDNA to guide adjuvant treatment in cancerEmma Sanderson, Peter Gibbs, Jeanne Tie
Cancers|October 16, 2024
Evolution of Liquid Biopsies for Detecting Pancreatic CancerRyan Munnings, Peter Gibbs, Belinda Lee
Pageof 43

Showing results (21-30 of 427) with videos related to

Sort By:
Pageof 43
Clinical Colorectal Cancer|July 27, 2015
Multidisciplinary Management of Locally Advanced Rectal Cancer--An Evolving Landscape?Margaret Lee, Peter Gibbs, Rachel Wong
JAMA Oncology|June 17, 2021
Is Universal Next-Generation Sequencing Testing of Patients With Advanced Cancer Ready for Prime Time?Catherine Dunn, Lucy Gately, Peter Gibbs
JAMA Oncology|April 3, 2020
Circulating Tumor DNA as a Prognostic Marker in Stage III Colon Cancer-ReplyJeanne Tie, Bert Vogelstein, Peter Gibbs
JAMA Surgery|February 23, 2022
Comment on Timing of Surgery For Patients With Rectal Cancers Not Responding to Preoperative ChemoradiationCatherine Dunn, Lucy Gately, Peter Gibbs
BMC Medicine|September 6, 2023
Re: Molecular testing to deliver personalised chemotherapy recommendationsPeter Gibbs, Wei Hong, Jeanne Tie
Hepatic Oncology|September 8, 2018
Radioembolization for hepatocellular carcinoma: current role and future directions - the medical oncologist's perspectivePeter Gibbs, Jeanne Tie, Lourens Bester
The New England Journal of Medicine|August 19, 2011
Bending the cost curve in cancer careKathryn Field, Ian Faragher, Peter Gibbs
Expert Review of Molecular Diagnostics|September 29, 2017
Circulating tumor DNA as a biomarker to guide therapy in post-operative locally advanced rectal cancer: the best option?Jeanne Tie, Christine Semira, Peter Gibbs
The Lancet Regional Health. Western Pacific|June 18, 2025
The emerging clinical utility of ctDNA to guide adjuvant treatment in cancerEmma Sanderson, Peter Gibbs, Jeanne Tie
Cancers|October 16, 2024
Evolution of Liquid Biopsies for Detecting Pancreatic CancerRyan Munnings, Peter Gibbs, Belinda Lee
Pageof 43